Serum albumin, genetic susceptibility, and risk of venous thromboembolism

被引:1
作者
Sun, Yuyang [1 ]
Deng, Jun [1 ]
Ding, Yajie [1 ]
Luo, Shanshan
Li, Si
Guan, Yunlong [2 ]
Cao, Xi [2 ]
Hao, Xingjie [2 ]
Hu, Yu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, 1277,Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
关键词
NEPHROTIC SYNDROME; THROMBOSIS; INFLAMMATION; ASSOCIATION; POPULATION; PREDICTORS; MORTALITY; EVENTS;
D O I
10.1016/j.rpth.2024.102509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous research on the association between serum albumin (ALB) and venous thromboembolism (VTE) has produced inconclusive results. The polygenic risk score is constructed from a set of independent risk variants associated with a disorder, enabling the identification of a larger fraction of the population at comparable or greater disease risk. It is still unknown whether ALB and genetic factors jointly contribute to the incidence of VTE. Objectives: The present study aimed to explore ALB, genetic susceptibility, and the risk of VTE. Methods: The present investigation was an analysis of prospectively collected data from UK Biobank, a population-based, longitudinal cohort. Cox proportional models were used to calculate hazard ratios and 95% CIs for VTE. The Kaplan-Meier curve was utilized to visualize the cumulative risk of VTE according to different serum ALB levels, and the restricted cubic spline model was leveraged to explore the exposure-response relationship among ALB levels and VTE risk. Results: During median follow-up of 13.5 years, 11,502 cases with VTE were diagnosed among 417,113 participants in the UK Biobank. The lower ALB levels were associated with a higher risk for VTE. Individuals with both a high genetic risk and lowest ALB level had the highest risk of VTE (hazard ratio, 3.89; 95% CI, 3.41-4.43), compared with those with low genetic risk and highest ALB level. The positive joint effects of low ALB and polygenic risk score increased the risk of VTE in individuals with high genetic risk. This study excluded non-European patients and primarily focused on the European population, which may limit the generalizability of the findings. Conclusion: Low serum ALB levels were linked to an increased risk of VTE, which was in accordance with a linear dose-response relationship. There was a positive additive effect of ALB and genetic susceptibility on the risk of VTE. ALB could serve as a biomarker for predicting the risk of VTE.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Risk of venous thromboembolism with glucocorticoids
    Heit, John A.
    NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (07) : 387 - 388
  • [22] Is ischaemia-modified albumin a test for venous thromboembolism?
    Hogg, Kerstin
    Hinchliffe, Edward
    Halsam, Shonagh
    Valkov, Alex
    Lecky, Fiona
    EMERGENCY MEDICINE JOURNAL, 2012, 29 (06) : 455 - 459
  • [23] Genetic risk factors for venous thromboembolism among infertile men with Klinefelter syndrome
    Hussein, Tarek M.
    Elneily, Dalia Abd Elmoaty
    Elsayed, Fatma Mohamed Abdelfattah
    El-Attar, Lama M.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2020, 20
  • [24] Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromso study
    Borch, K. H.
    Braekkan, S. K.
    Mathiesen, E. B.
    Njolstad, I.
    Wilsgaard, T.
    Stormer, J.
    Hansen, J. -B
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) : 739 - 745
  • [25] Association between features of COPD and risk of venous thromboembolism
    Dong, Weigang
    Zhu, Yaqian
    Du, Yan
    Ma, Shuping
    CLINICAL RESPIRATORY JOURNAL, 2019, 13 (08) : 499 - 504
  • [26] RNA expression and risk of venous thromboembolism in lung cancer
    Sussman, Tamara A.
    Abazeed, Mohamed E.
    McCrae, Keith R.
    Khorana, Alok A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (01) : 117 - 123
  • [27] Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
    Hohaus, Stefan
    Bartolomei, Francesca
    Cuccaro, Annarosa
    Maiolo, Elena
    Alma, Eleonora
    D'Alo, Francesco
    Bellesi, Silvia
    Rossi, Elena
    De Stefano, Valerio
    CANCERS, 2020, 12 (05)
  • [28] Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism
    Skille, Hanne
    Paulsen, Benedikte
    Hveem, Kristian
    Gabrielsen, Maiken E.
    Brumpton, Ben
    Hindberg, Kristian
    Gran, Olga V.
    Rosendaal, Frits R.
    Braekkan, Sigrid K.
    Hansen, John-Bjarne
    HAEMATOLOGICA, 2020, 105 (07) : E358 - E360
  • [29] Lifestyle Moderates Genetic Risk of Venous Thromboembolism The ARIC Study
    Evans, Christina R.
    Hong, Ching-Ping
    Folsom, Aaron R.
    Heckbert, Susan R.
    Smith, Nicholas L.
    Wiggins, Kerri
    Lutsey, Pamela L.
    Cushman, Mary
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (11) : 2756 - 2763
  • [30] Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study
    Folsom, A. R.
    Roetker, N. S.
    Rosamond, W. D.
    Heckbert, S. R.
    Basu, S.
    Cushman, M.
    Lutsey, P. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) : 1455 - 1460